These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neonatal MSG reduces hypothalamic DA, beta-endorphin, and delays weight gain in genetically obese (A viable yellow/alpha) mice. Caputo FA; Ali SF; Wolff GL; Scallet AC Pharmacol Biochem Behav; 1996 Feb; 53(2):425-32. PubMed ID: 8808153 [TBL] [Abstract][Full Text] [Related]
23. Diabetogenic response to streptozotocin varies among obese yellow and among lean agouti (BALB/c x VY)F1 hybrid mice. Wolff GL; Greenman DL; Frigeri LG; Morrissey RL; Suber RL; Felton RP Proc Soc Exp Biol Med; 1990 Feb; 193(2):155-63. PubMed ID: 2137249 [TBL] [Abstract][Full Text] [Related]
24. Pancreatic islet cells in preobese yellow Avy/- mice: relation to adult hyperinsulinemia and obesity. Warbritton A; Gill AM; Yen TT; Bucci T; Wolff GL Proc Soc Exp Biol Med; 1994 Jun; 206(2):145-51. PubMed ID: 8208738 [TBL] [Abstract][Full Text] [Related]
25. Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c X VY) F1 hybrid mice. Wolff GL; Kodell RL; Cameron AM; Medina D J Toxicol Environ Health; 1982 Jul; 10(1):131-42. PubMed ID: 6290678 [TBL] [Abstract][Full Text] [Related]
26. Age-specific locomotor response to nicotine in yellow and mottled yellow A(vy)/a mice. Dingman MA; Gyekis JP; Whetzel CA; Klein LC; Vandenbergh DJ BMC Res Notes; 2013 Dec; 6():497. PubMed ID: 24289264 [TBL] [Abstract][Full Text] [Related]
27. Differential spontaneous transformation in vitro of newly established mouse fibroblast lines carrying or lacking the viable yellow mutation (Avy) of the mouse agouti locus. Hsiao WL; Wolff GL; North BM; Ollmann MM; Barsh GS; Fan H Mol Carcinog; 1996 Jan; 15(1):70-80. PubMed ID: 8561869 [TBL] [Abstract][Full Text] [Related]
28. An analysis of the relationships among obesity, plasma insulin and hepatic lipogenic enzymes in "viable yellow obese" mice (Avy/a). Yen TT; Greenberg MM; Yu PL; Pearson DV Horm Metab Res; 1976 May; 8(3):159-66. PubMed ID: 7520 [TBL] [Abstract][Full Text] [Related]
29. Soy protein isolate reduces hepatosteatosis in yellow Avy/a mice without altering coat color phenotype. Badger TM; Ronis MJ; Wolff G; Stanley S; Ferguson M; Shankar K; Simpson P; Jo CH Exp Biol Med (Maywood); 2008 Oct; 233(10):1242-54. PubMed ID: 18791133 [TBL] [Abstract][Full Text] [Related]
30. Influence of genetic obesity, food intake and adrenalectomy in mice on selected trace element-dependent protective enzymes. Prohaska JR; Wittmers LE; Haller EW J Nutr; 1988 Jun; 118(6):739-46. PubMed ID: 3373340 [TBL] [Abstract][Full Text] [Related]
31. Effects of hypophysectomy and the insulin-like and anti-insulin pituitary peptides on carbohydrate metabolism in yellow Avy/A (BALB/c x VY)F1 hybrid mice. Salem MA; Lewis UJ; Haro LS; Kishi K; McAllister DL; Seavey BK; Bee G; Wolff GL Proc Soc Exp Biol Med; 1989 Sep; 191(4):408-19. PubMed ID: 2672006 [TBL] [Abstract][Full Text] [Related]
32. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. Yen TT; Gill AM; Frigeri LG; Barsh GS; Wolff GL FASEB J; 1994 May; 8(8):479-88. PubMed ID: 8181666 [TBL] [Abstract][Full Text] [Related]
33. Obesity as a pleiotropic effect of gene action. Wolff GL J Nutr; 1997 Sep; 127(9):1897S-1901S. PubMed ID: 9278578 [TBL] [Abstract][Full Text] [Related]
34. Influence of background genome on enzymatic characteristics of yellow (A v -, A vy -) mice. Wolff GL; Pitot HC Genetics; 1973 Jan; 73(1):109-23. PubMed ID: 4405752 [TBL] [Abstract][Full Text] [Related]
35. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice. Salem MA; Wolff GL Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747 [TBL] [Abstract][Full Text] [Related]
36. Control of obesity in Avy/a mice by 5alpha-androstan-17-one. Yen TT; Allan JA; Pearson DV; Acton JM Experientia; 1978 Dec; 34(12):1542-3. PubMed ID: 729710 [TBL] [Abstract][Full Text] [Related]
37. A study of gender, strain and age differences in mouse liver glutathione-S-transferase. Egaas E; Falls JG; Dauterman WC Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jan; 110(1):35-40. PubMed ID: 7749601 [TBL] [Abstract][Full Text] [Related]
38. Thermogenesis and weight control. Yen TT; McKee MM; Stamm NB Int J Obes; 1984; 8 Suppl 1():65-78. PubMed ID: 6152557 [TBL] [Abstract][Full Text] [Related]
39. Differences in the influence of diet on hepatic glutathione S-transferase activity and glutathione content between young and old C57 black female mice. Carrillo MC; Kitani K; Kanai S; Sato Y; Nokubo M; Ohta M; Otsubo K Mech Ageing Dev; 1989 Jan; 47(1):1-15. PubMed ID: 2725067 [TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid reduces the systemic toxicity of 1,2-dichloro,4-nitrobenzene by stimulating hepatic glutathione S-transferase in mice. Kitani K; Kanai S; Sato Y; Ohta M; Nokubo M Life Sci; 1994; 54(14):983-9. PubMed ID: 8139388 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]